Prediction, structure analysis, experimental affinity, and clinical studies of patients with severe COVID-19 have indicated that some ACE2 polymorphisms have a higher affinity for protein S. During SARS-CoV-2 infection, severe inflammation favors the expression of ACE2 and TLR-4. The gene discussed is PROS1; the disease is COVID-19.